Diagnostics News and Research

RSS
Majority of qualified patients fail to receive lifesaving treatment for sudden cardiac arrest: Study

Majority of qualified patients fail to receive lifesaving treatment for sudden cardiac arrest: Study

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

Plenary sessions at AdvaMed 2013 conference to explore new Medicare payment initiatives

Plenary sessions at AdvaMed 2013 conference to explore new Medicare payment initiatives

Advamed 2013 conference to focus on global opportunities and challenges in medical technology industry

Advamed 2013 conference to focus on global opportunities and challenges in medical technology industry

Researchers develop new, improved technique for single-cell gene expression analysis

Researchers develop new, improved technique for single-cell gene expression analysis

Avon Foundation for Women launches competition to bring emerging breast cancer technologies to market

Avon Foundation for Women launches competition to bring emerging breast cancer technologies to market

SeraCare Life Sciences announces expansion of R&D facilities in Milford, Massachusetts

SeraCare Life Sciences announces expansion of R&D facilities in Milford, Massachusetts

Vera and Paul Guerin Family Congenital Heart Program to be established in Cedars-Sinai Heart Institute

Vera and Paul Guerin Family Congenital Heart Program to be established in Cedars-Sinai Heart Institute

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.